Cytocom, Inc. CBLI
3.17 +3.17
Day range unavailable
52-week range unavailable
News
seekingalpha.com Cytocom, Inc. (CBLI) CEO Michael Handley on Q2 2021 Results - Earnings Call Transcript Cytocom, Inc. (CBLI) CEO Michael Handley on Q2 2021 Results - Earnings Call Transcript
prnewswire.com Cytocom, Inc. Reports Second Quarter 2021 Financial Results FORT COLLINS, Colo., Aug. 16, 2021 /PRNewswire/ -- Cytocom, Inc. (Nasdaq: CBLI), a leading biopharmaceutical company creating next-generation immune therapies for serious medical conditions that…
prnewswire.com Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference FORT COLLINS, Colo., Aug. 11, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and…
prnewswire.com Cytocom, Inc. to Report Second Quarter 2021 Financial Results FORT COLLINS, Colo., Aug. 10, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and…
prnewswire.com Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19 FORT COLLINS, Colo., Aug. 9, 2021 /PRNewswire/ -- Cytocom Inc. (NASDAQ: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and…
prnewswire.com Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs FORT COLLINS, Colo., Aug. 5, 2021 /PRNewswire/ -- Cytocom Inc. (NASDAQ: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and…
prnewswire.com Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing FORT COLLINS, Colo., July 29, 2021 /PRNewswire/ -- Cytocom, Inc., (NASDAQ: CBLI), a leading biopharmaceutical company developing next generation therapies that focus on immune homeostasis, has…
prnewswire.com Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger FORT COLLINS, Colo. and BUFFALO, N.Y.
pulse2.com CBLI Stock Price Increases Over 15% Pre-Market: Why It Happened The stock price of Cleveland BioLabs, Inc. (Nasdaq: CBLI) increased by over 15% pre-market. This is why it happened.
prnewswire.com Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Declared Effective by SEC FORT COLLINS, Colo. and BUFFALO, N.Y.
accesswire.com Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532 The substantially improved pharmacological profile of GP532 opens new opportunities for broader therapeutic applications of this class of pharmaceuticals BUFFALO, NY / ACCESSWIRE / April 14, 2021 /…
benzinga.com 50 Biggest Movers From Yesterday Gainers
prnewswire.com SHAREHOLDER ALERT: WeissLaw LLP Reminds NTWN, TLRY, CBLI, and AKER Shareholders About Its Ongoing Investigations NEW YORK, March 12, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your…
pulse2.com CBLI Stock Price Increases Over 60% Pre-Market: Why It Happened The stock price of Cleveland BioLabs, Inc. (NASDAQ: CBLI) is trading at over 60% pre-market. This is why it happened.
benzinga.com Stocks That Hit 52-Week Highs On Wednesday This morning 194 companies reached new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Thursday During Thursday's morning session, 255 companies made new 52-week highs.
prnewswire.com SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - CBLI, IPHI, CBMG, WTRE, CIT NEW YORK, Dec. 28, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cleveland BioLabs, Inc. (NASDAQ: CBLI) concerning…
businesswire.com CLEVELAND BIOLABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cleveland BioLabs, Inc. - CBLI NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Cleveland…
businesswire.com CLEVELAND BIOLABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cleveland BioLabs, Inc. - CBLI NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Cleveland…- benzinga.com 40 Stocks Moving in Wednesday's Pre-Market Session Gainers Astrotech Corporation (NASDAQ: ASTC) rose 217.5% to $5.27 in pre-market trading after the company announced partnership with Cleveland Clinic to develop a rapid COVID-19 breath test.
benzinga.com 60 Biggest Movers From Yesterday Gainers Dragon Victory International Limited (NASDAQ: LYL) shares jumped 47.6% to close at $3.75 on Tuesday in sympathy with the overall market amid macro optimism on US stimulus hopes. Dragon…
businesswire.com Cleveland BioLabs Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Cleveland BioLabs, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – CBLI NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Cytocom, Inc. is fair to…- benzinga.com 12 Healthcare Stocks Moving In Tuesday's Intraday Session Gainers
- benzinga.com 50 Stocks Moving In Tuesday's Mid-Day Session Gainers Cleveland BioLabs, Inc. (NASDAQ: CBLI) shares jumped 105.5% to $4.46 after the company announced a definitive merger agreement to combine its business with Cytocom in an all-stock transaction.
businesswire.com Neutropenia Pipeline Monitor, 2020: Drugs, Companies, Clinical Trials, R&D Updates, Status and Outlook - ResearchAndMarkets.com The
thelincolnianonline.com Cleveland BioLabs (NASDAQ:CBLI) Stock Price Down 9.8% Shares of Cleveland BioLabs, Inc. (NASDAQ:CBLI) fell 9.8% during mid-day trading on Thursday . The company traded as low as $2.36 and last traded at $2.57, 9,782 shares changed hands during mid-day…
thelincolnianonline.com Cleveland BioLabs (NASDAQ:CBLI) Share Price Crosses Above Two Hundred Day Moving Average of $1.91 Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.91 and traded as high as…
benzinga.com 144 Biggest Movers From Friday 
benzinga.com 136 Biggest Movers From Yesterday - benzinga.com 108 Biggest Movers From Yesterday
- benzinga.com 95 Biggest Movers From Yesterday
benzinga.com 77 Biggest Movers From Yesterday 
benzinga.com 55 Stocks Moving In Monday's Mid-Day Session - benzinga.com 71 Biggest Movers From Yesterday
- benzinga.com Mid-Afternoon Market Update: Crude Oil Down 2%; NeuroMetrix Shares Plummet
- benzinga.com Mid-Day Market Update: Dow Falls 1.5%; NanoViricides Shares Spike Higher
- benzinga.com 40 Stocks Moving In Monday's Mid-Day Session
- benzinga.com Stocks That Hit 52-Week Highs On Monday
- benzinga.com Stocks That Hit 52-Week Lows On Monday
benzinga.com Stocks That Hit 52-Week Lows On Thursday - benzinga.com Stocks That Hit 52-Week Lows On Wednesday
- benzinga.com Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019
- benzinga.com Stocks Which Set New 52-Week Low Friday, October 26th
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 23rd
- benzinga.com Stocks to Watch for Monday 7/18/2011: Fresh 52 Week Highs and Lows